NCT07316764

Brief Summary

The project aims to optimise functional rehabilitation programmes for people with multiple sclerosis. Investigators are proposing eccentric cycling as a new exercise modality for treating these patients. Based on previous results in healthy subjects, investigators will attempt to define the optimal parameters of this new modality (in terms of duration, intensity, frequency, etc.). Investigators also aim to demonstrate the effectiveness of this training (compared to conventional training) in improving muscle function, functional capacity, perception of chronic fatigue, quality of life, physical condition, and neurological and cognitive function.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
5mo left

Started Jan 2026

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Jan 2026Dec 2026

First Submitted

Initial submission to the registry

December 8, 2025

Completed
24 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

9 months

First QC Date

December 8, 2025

Last Update Submit

December 23, 2025

Conditions

Keywords

eccentric cyclingmultiple sclerosiseccentric trainingneurorehabilitationphysical therapyneuro-degenerative disease

Outcome Measures

Primary Outcomes (2)

  • Maximal Isometric Force

    Maximal Isometric Force (in Newton-meters - Nm) of the quadriceps will be measured using a fixed dynamometer (Kinvent), at 90 degrees of knee flexion.

    At baseline and endline of intervention (Week 1 and 14)

  • Walking distance

    6 minutes walking test and 2 minutes walking test will be performed to measure the walking capacities (in meters) of participants.

    At baseline and endline of intervention (Week 1 and 14)

Secondary Outcomes (11)

  • Handgrip strength

    At baseline and endline of intervention (Week 1 and 14)

  • Spasticity

    At baseline and endline of intervention (Week 1 and 14)

  • Timed up and go

    At baseline and endline of intervention (Week 1 and 14)

  • Neurocognitive capacity

    At baseline and endline of intervention (Week 1 and 14)

  • Berg Balance Scale

    At baseline and endline of intervention (Week 1 and 14)

  • +6 more secondary outcomes

Other Outcomes (8)

  • Height

    At baseline and endline of intervention (Week 1 and 14)

  • Weight

    At baseline and endline of intervention (Week 1 and 14)

  • Body fat percentage

    At baseline and endline of intervention (Week 1 and 14)

  • +5 more other outcomes

Study Arms (2)

Eccentric group

EXPERIMENTAL
Other: Eccentric training

Concentric group

ACTIVE COMPARATOR
Other: Concentric training

Interventions

Concentric cycling training

Concentric group

Eccentric cycling training

Eccentric group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of multiple sclerosis
  • Multiple sclerosis: EDSS score \< 7
  • Age under 75 years
  • Stable disease state
  • Written medical clearance authorizing participation
  • Legal adult status
  • Written informed consent, with demonstrated understanding of the consent form (via a few specific questions)
  • Ability to mobilize independently (e.g., transfers, walking)

You may not qualify if:

  • One or more contraindications to physical activity
  • Significant comorbidities
  • Current hospitalization or undergoing changes in medication
  • Active flare-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liege University

Liège, Liège, 4000, Belgium

Location

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Stéphanie HODY, PhD

    Department of Physical Activity and Rehabilitation Sciences, University of Liege and University Hospital of Liege, Liege, Belgium

    STUDY CHAIR

Central Study Contacts

Benoît Vandenbroeck, PhD Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be split in 2 groups : one following an eccentric cycling training one following a concentric cycling training
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

December 8, 2025

First Posted

January 5, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 5, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations